linaclotide
linaclotide is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand name including Linzess. Available dosage forms: capsule, gelatin coated, powder.
Drug Details
- Generic Name
- linaclotide
- Brand Names
- Linzess
- Application Number
- NDA202811
- Sponsor
- Allergan, Inc.
- NDC Codes
- 8
- Dosage Forms
- CAPSULE, GELATIN COATED, POWDER
- Routes
- ORAL
- Active Ingredients
- LINACLOTIDE
Indications and Usage
1 INDICATIONS AND USAGE LINZESS is indicated for the treatment of: • irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients 7 years of age and older • chronic idiopathic constipation (CIC) in adults • functional constipation (FC) in pediatric patients 2 years of age and older LINZESS is a guanylate cyclase-C agonist indicated for treatment of: Irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients 7 years of age and older. ( 1 ) Chronic idiopathic constipation (CIC) in adults. ( 1 ) Functional constipation (FC) in pediatric patients 2 years of age and older. ( 1 )